Skip to main content
Erschienen in: American Journal of Clinical Dermatology 2/2010

01.04.2010 | Review Article

The Purple Digit

An Algorithmic Approach to Diagnosis

verfasst von: Patrick J. Brown, Matthew J. Zirwas, Dr Joseph C. English III

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

The acute onset of purple digits is a concerning manifestation and may represent underlying, potentially life-threatening disease. Correctly identifying the etiology of purple digits is essential to proper management, and can aid in the diagnosis of systemic disease. Multiple causes of purple digits and significant overlap in clinical presentation can make diagnosis difficult. Despite the various causes of acute purple digits in the published literature, an algorithmic approach to the evaluation and management of the most common and alarming etiologies has yet to be established.
The initial step in evaluating a patient with purple digits is to determine if the cause is associated with hypoxemia or trauma. If the patient is in a stable condition, the dermatologist needs to determine if the process could be related to cold exposure such as Raynaud phenomenon, acrocyanosis, pernio, cryoglobulinemia or frostbite. If the disease occurs independent of temperature, physical examination and histological evaluation of the skin is recommended. The lack of peripheral pulses are concerning for acute arterial thrombosis from peripheral vascular disease or arterial embolism. Non-blanching skin changes on the digit that lack inflammation and microthrombosis most likely represent a bleeding or platelet abnormality; however, if microthrombi are identified a more life-threatening processes such as purpura fulminans or embolic phenomenon may be occurring. Evidence of blood vessel inflammation suggests a leukocytoclastic vasculitis. The patient with a purple blanching digit and normal pulses requires an extensive historical review to help determine the cause. This review presents an algorithmic approach to assist in the evaluation and management of the purple digit.
Literatur
1.
Zurück zum Zitat O’Keeffe ST, Woods BO, Breslin DJ, et al. Blue toe syndrome: causes and management. Arch Intern Med 1992; 152: 2197–202PubMedCrossRef O’Keeffe ST, Woods BO, Breslin DJ, et al. Blue toe syndrome: causes and management. Arch Intern Med 1992; 152: 2197–202PubMedCrossRef
2.
Zurück zum Zitat Abdelmalek MF, Spitteli PC. 79-year-old woman with blue toes. Mayo Clin Proc 1995; 70: 292–5PubMedCrossRef Abdelmalek MF, Spitteli PC. 79-year-old woman with blue toes. Mayo Clin Proc 1995; 70: 292–5PubMedCrossRef
3.
Zurück zum Zitat Bouaziz JD, Barete S, Pelletier FL, et al. Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 2007; 16: 163–7PubMed Bouaziz JD, Barete S, Pelletier FL, et al. Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 2007; 16: 163–7PubMed
4.
Zurück zum Zitat Ballas M, Kraut EH. Bleeding and bruising: a diagnostic work-up. Am Fam Physician 2008; 77: 117–24 Ballas M, Kraut EH. Bleeding and bruising: a diagnostic work-up. Am Fam Physician 2008; 77: 117–24
5.
Zurück zum Zitat Hall EL. Role of surgical intervention in the management of crotaline snake envenomation. Ann Emerg Med 2001; 37: 175–80PubMedCrossRef Hall EL. Role of surgical intervention in the management of crotaline snake envenomation. Ann Emerg Med 2001; 37: 175–80PubMedCrossRef
6.
Zurück zum Zitat Roberts JR, Otten EJ. Snakebites and other reptiles. In: Goldfrank LR, editor. Goldrank’s toxicologic emergencies. Stamford (CT): Appleton & Lange, 1998: 1603–23 Roberts JR, Otten EJ. Snakebites and other reptiles. In: Goldfrank LR, editor. Goldrank’s toxicologic emergencies. Stamford (CT): Appleton & Lange, 1998: 1603–23
7.
Zurück zum Zitat Açikalin A, Gökel Y, Kuvandik G, et al. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases. Am J Emerg Med 2008; 26: 402–7PubMedCrossRef Açikalin A, Gökel Y, Kuvandik G, et al. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases. Am J Emerg Med 2008; 26: 402–7PubMedCrossRef
8.
Zurück zum Zitat Vetter RS, Swanson DL. Of spiders and zebras: publication of inadequately documented loxoscelism case reports. J Am Acad Dermatol 2007; 56: 1063–4PubMedCrossRef Vetter RS, Swanson DL. Of spiders and zebras: publication of inadequately documented loxoscelism case reports. J Am Acad Dermatol 2007; 56: 1063–4PubMedCrossRef
9.
Zurück zum Zitat Swanson DL, Vetter RS. Bites of brown recluse spiders and suspected necrotic arachnidism. N Engl J Med 2005; 352: 700–7PubMedCrossRef Swanson DL, Vetter RS. Bites of brown recluse spiders and suspected necrotic arachnidism. N Engl J Med 2005; 352: 700–7PubMedCrossRef
10.
11.
Zurück zum Zitat Nousari HC, Kimyai-Asadi A, Anhalt GJ. Chronic idiopathic cyanosis. J Am Acad Dermatol 2001; 45: S207–8CrossRef Nousari HC, Kimyai-Asadi A, Anhalt GJ. Chronic idiopathic cyanosis. J Am Acad Dermatol 2001; 45: S207–8CrossRef
12.
Zurück zum Zitat Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34: 646–56PubMedCrossRef Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34: 646–56PubMedCrossRef
13.
Zurück zum Zitat Kane GC, Hoehn SM, Behrenbeck TR, et al. Benzocain-induced methemoglobinemia based on the Mayo Clinic experience from 28478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med 2007; 167: 1977–82PubMedCrossRef Kane GC, Hoehn SM, Behrenbeck TR, et al. Benzocain-induced methemoglobinemia based on the Mayo Clinic experience from 28478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med 2007; 167: 1977–82PubMedCrossRef
14.
Zurück zum Zitat Dötsch J, Demirakça S, Kratz M, et al. Comparison of methylene blue, riboflavin, and N-acetylcysteine for the reduction of nitric oxide-induced methemoglobinemia. Crit Care Med 2000; 28: 958–61PubMedCrossRef Dötsch J, Demirakça S, Kratz M, et al. Comparison of methylene blue, riboflavin, and N-acetylcysteine for the reduction of nitric oxide-induced methemoglobinemia. Crit Care Med 2000; 28: 958–61PubMedCrossRef
15.
Zurück zum Zitat George R, Fulchiero GJ, Marks JG, et al. Neurovascular instability syndrome: a unifying term to describe the coexistence of temperaturerelated vascular disorders in affected patients. Arch Dermatol 2007; 143: 274–5PubMedCrossRef George R, Fulchiero GJ, Marks JG, et al. Neurovascular instability syndrome: a unifying term to describe the coexistence of temperaturerelated vascular disorders in affected patients. Arch Dermatol 2007; 143: 274–5PubMedCrossRef
16.
17.
Zurück zum Zitat LeRoy EC, Medsger TA. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 485–8PubMed LeRoy EC, Medsger TA. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 485–8PubMed
18.
Zurück zum Zitat Landry GJ, Edwards JM, McLafferty RB, et al. Long-term outcome of Raynaud’s syndrome in a prospectively analyzed patient cohort. J Vasc Surg 1996; 23: 76–8PubMedCrossRef Landry GJ, Edwards JM, McLafferty RB, et al. Long-term outcome of Raynaud’s syndrome in a prospectively analyzed patient cohort. J Vasc Surg 1996; 23: 76–8PubMedCrossRef
19.
Zurück zum Zitat Spencer-Green G. Outcomes in primary Raynaud phenomenon: a metaanalysis of the frequency, rates, and predictors of transition to secondary disease. Arch Intern Med 1998; 158: 595–600PubMedCrossRef Spencer-Green G. Outcomes in primary Raynaud phenomenon: a metaanalysis of the frequency, rates, and predictors of transition to secondary disease. Arch Intern Med 1998; 158: 595–600PubMedCrossRef
20.
Zurück zum Zitat Berlin AL, Pehr K. Coexistence of erythromelalgia and Raynaud’s phenomenon. J Am Acad Dermatol 2004; 50: 456–60PubMedCrossRef Berlin AL, Pehr K. Coexistence of erythromelalgia and Raynaud’s phenomenon. J Am Acad Dermatol 2004; 50: 456–60PubMedCrossRef
21.
Zurück zum Zitat Chester MH. Segmental manifestation of reflex sympathetic dystrophy syndrome limited to one finger. Anesthesiology 1990; 73: 558–61PubMedCrossRef Chester MH. Segmental manifestation of reflex sympathetic dystrophy syndrome limited to one finger. Anesthesiology 1990; 73: 558–61PubMedCrossRef
22.
Zurück zum Zitat Ingram GJ, Scher RK, Lally EV. Reflex sympathetic dystrophy following nail biopsy. J Am Acad Dermatol 1987; 16: 253–6PubMedCrossRef Ingram GJ, Scher RK, Lally EV. Reflex sympathetic dystrophy following nail biopsy. J Am Acad Dermatol 1987; 16: 253–6PubMedCrossRef
23.
Zurück zum Zitat Epstein E. Intralesional bleomycin and Raynaud’s phenomenon. J Am Acad Dermatol 1991; 24: 785–6PubMedCrossRef Epstein E. Intralesional bleomycin and Raynaud’s phenomenon. J Am Acad Dermatol 1991; 24: 785–6PubMedCrossRef
24.
Zurück zum Zitat Vanhooteghem O, Richert B, de la Brassinne M. Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin. Pediatr Dermatol 2001; 18: 249–51PubMedCrossRef Vanhooteghem O, Richert B, de la Brassinne M. Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin. Pediatr Dermatol 2001; 18: 249–51PubMedCrossRef
26.
Zurück zum Zitat Khan F. Vascular abnormalities in Raynaud’s phenomenon. Scott Med J 1999; 44: 4–6PubMed Khan F. Vascular abnormalities in Raynaud’s phenomenon. Scott Med J 1999; 44: 4–6PubMed
27.
Zurück zum Zitat Vinjar B, Stewart M. Oral vasodilators for primary Raynaud’s phenomenon. Cochrane Database Syst Rev 2008; (2): CD006687 Vinjar B, Stewart M. Oral vasodilators for primary Raynaud’s phenomenon. Cochrane Database Syst Rev 2008; (2): CD006687
28.
Zurück zum Zitat Creager MA, Loscalzo J. Vascular diseases of the extremities. In: Fauci AS, Braunwald E, Kasper DL, et al., editors. Harrison’s principles of internal medicine. New York: McGraw Hill, 2008: 1568–75 Creager MA, Loscalzo J. Vascular diseases of the extremities. In: Fauci AS, Braunwald E, Kasper DL, et al., editors. Harrison’s principles of internal medicine. New York: McGraw Hill, 2008: 1568–75
29.
Zurück zum Zitat Iguchi S, Toba K, Fuse I, et al. Severe cryoglobulinemia in a patient with asymptomatic hepatitis C virus infection. Intern Med 1996; 35: 712–6PubMedCrossRef Iguchi S, Toba K, Fuse I, et al. Severe cryoglobulinemia in a patient with asymptomatic hepatitis C virus infection. Intern Med 1996; 35: 712–6PubMedCrossRef
30.
Zurück zum Zitat Lauchli S, Widmer L, Lautenschlager S. Cold agglutinin disease: the importance of cutaneous signs. Dermatology 2001; 202: 356–8PubMedCrossRef Lauchli S, Widmer L, Lautenschlager S. Cold agglutinin disease: the importance of cutaneous signs. Dermatology 2001; 202: 356–8PubMedCrossRef
31.
Zurück zum Zitat Diógenes MJN, Diógenes PCN, Morais Carneiro RM, et al. Cutaneous manifestations associated with antiphospholipid antibodies. Int J Dermatol 2004; 43: 632–7PubMedCrossRef Diógenes MJN, Diógenes PCN, Morais Carneiro RM, et al. Cutaneous manifestations associated with antiphospholipid antibodies. Int J Dermatol 2004; 43: 632–7PubMedCrossRef
32.
33.
Zurück zum Zitat Hoegl L, Thoma-Greber E, Poppinger J, et al. Butyl nitrite induced acrocyanosis in an HIV-infected patient. Arch Dermatol 1999; 135: 90–1PubMedCrossRef Hoegl L, Thoma-Greber E, Poppinger J, et al. Butyl nitrite induced acrocyanosis in an HIV-infected patient. Arch Dermatol 1999; 135: 90–1PubMedCrossRef
34.
Zurück zum Zitat Campo-Voegeli A, Estrach T, Marti RM, et al. Acrocyanosis induced by interferon alpha (2a). Dermatology 1998; 196: 361–3PubMedCrossRef Campo-Voegeli A, Estrach T, Marti RM, et al. Acrocyanosis induced by interferon alpha (2a). Dermatology 1998; 196: 361–3PubMedCrossRef
35.
Zurück zum Zitat Ozaras R, Yemisen M, Mete B, et al. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex [letter]. Mycoses 2007; 50: 242PubMedCrossRef Ozaras R, Yemisen M, Mete B, et al. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex [letter]. Mycoses 2007; 50: 242PubMedCrossRef
36.
Zurück zum Zitat Poszepcyznska-Guingné E, Viguier M, Chosidow O, et al. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol 2002; 47: 47–52CrossRef Poszepcyznska-Guingné E, Viguier M, Chosidow O, et al. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol 2002; 47: 47–52CrossRef
37.
Zurück zum Zitat Grosso S, Mostardini R, Farnetani MA, et al. Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 2002; 249: 1446–50PubMedCrossRef Grosso S, Mostardini R, Farnetani MA, et al. Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 2002; 249: 1446–50PubMedCrossRef
38.
Zurück zum Zitat Fleming C, Rennie A, Fallowfield M, et al. Cutaneous manifestations of fucosidosis. Br J Dermatol 1997; 136: 594–7PubMedCrossRef Fleming C, Rennie A, Fallowfield M, et al. Cutaneous manifestations of fucosidosis. Br J Dermatol 1997; 136: 594–7PubMedCrossRef
39.
Zurück zum Zitat Dowd PM. Reactions to cold. In: Burns T, Breathnach S, Cox N, et al., editors. Rook’s textbook of dermatology. Oxford: Blackwell, 2004: 23.1–23.17 Dowd PM. Reactions to cold. In: Burns T, Breathnach S, Cox N, et al., editors. Rook’s textbook of dermatology. Oxford: Blackwell, 2004: 23.1–23.17
40.
Zurück zum Zitat Twist DJ. Acrocyanosis in a spinal cord injured patient-effects of computercontrolled neuromuscular electrical stimulation: a case report. Phys Ther 1990; 70: 45–9PubMed Twist DJ. Acrocyanosis in a spinal cord injured patient-effects of computercontrolled neuromuscular electrical stimulation: a case report. Phys Ther 1990; 70: 45–9PubMed
42.
Zurück zum Zitat Carpenter PK, Morris D. Association of acrocyanosis with Asperger’s syndrome. J Ment Defic Res 1990; 34: 87–90PubMed Carpenter PK, Morris D. Association of acrocyanosis with Asperger’s syndrome. J Ment Defic Res 1990; 34: 87–90PubMed
43.
Zurück zum Zitat Giudice PD, Jacques D, Dellamonica P. Hand edema and acrocyanosis: “puffy hand syndrome”. Arch Dermatol 2006; 142: 1084–5PubMed Giudice PD, Jacques D, Dellamonica P. Hand edema and acrocyanosis: “puffy hand syndrome”. Arch Dermatol 2006; 142: 1084–5PubMed
44.
Zurück zum Zitat Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6: 165–73PubMedCrossRef Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6: 165–73PubMedCrossRef
45.
Zurück zum Zitat Schulze UM, Pettke-Rank CV, Kreienkamp M, et al. Dermatologic findings in anorexia and bulimia nervosa of childhood and adolescence. Pediatr Dermatol 1999; 16: 90–4PubMedCrossRef Schulze UM, Pettke-Rank CV, Kreienkamp M, et al. Dermatologic findings in anorexia and bulimia nervosa of childhood and adolescence. Pediatr Dermatol 1999; 16: 90–4PubMedCrossRef
46.
Zurück zum Zitat Solak Y, Aksoy S, Kilickap S, et al. Acrocyanosis as a presenting symptom of Hodgkin lymphoma. Am J Hematol 2006; 81: 151–2PubMedCrossRef Solak Y, Aksoy S, Kilickap S, et al. Acrocyanosis as a presenting symptom of Hodgkin lymphoma. Am J Hematol 2006; 81: 151–2PubMedCrossRef
47.
Zurück zum Zitat Legrain S, Raguin G, Piette JC. Digital necrosis revealing ovarian cancer. Dermatology 1999; 199: 183–4PubMedCrossRef Legrain S, Raguin G, Piette JC. Digital necrosis revealing ovarian cancer. Dermatology 1999; 199: 183–4PubMedCrossRef
48.
Zurück zum Zitat Martin L, Sturgess A, Sillence D, et al. Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparesthesia. Australas J Dermatol 2007; 48: 40–2PubMedCrossRef Martin L, Sturgess A, Sillence D, et al. Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparesthesia. Australas J Dermatol 2007; 48: 40–2PubMedCrossRef
49.
Zurück zum Zitat Abeles H. Puffy-hand sign of drug addiction [letter]. N Engl J Med 1965; 273: 1167 Abeles H. Puffy-hand sign of drug addiction [letter]. N Engl J Med 1965; 273: 1167
50.
Zurück zum Zitat Knize DM, Weatherley-White RCA, Paton BC, et al. Prognostic factors in the management of frostbite. J Trauma 1969; 9: 749–59PubMedCrossRef Knize DM, Weatherley-White RCA, Paton BC, et al. Prognostic factors in the management of frostbite. J Trauma 1969; 9: 749–59PubMedCrossRef
51.
Zurück zum Zitat Meffert JJ. Environmental skin diseases and the impact of common dermatoses on medical readiness. Dermatol Clin 1999; 17: 1–17PubMed Meffert JJ. Environmental skin diseases and the impact of common dermatoses on medical readiness. Dermatol Clin 1999; 17: 1–17PubMed
52.
Zurück zum Zitat Urschel JD. Frostbite: predisposing factors and predictors of poor outcome. J Trauma 1990; 30: 340–2PubMedCrossRef Urschel JD. Frostbite: predisposing factors and predictors of poor outcome. J Trauma 1990; 30: 340–2PubMedCrossRef
53.
Zurück zum Zitat Murphy JV, Banwell PE, Roberts AH, et al. Frostbite: pathogenesis and treatment. J Trauma 2000; 48: 171–8PubMedCrossRef Murphy JV, Banwell PE, Roberts AH, et al. Frostbite: pathogenesis and treatment. J Trauma 2000; 48: 171–8PubMedCrossRef
54.
Zurück zum Zitat Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg 2007; 142: 546–51PubMedCrossRef Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg 2007; 142: 546–51PubMedCrossRef
55.
Zurück zum Zitat McCleskey PE, Winter KJ, Devillez RL. Tender papules on the hands: idiopathic chilblains (perniosis). Arch Dermatol 2006; 142: 1501–6PubMedCrossRef McCleskey PE, Winter KJ, Devillez RL. Tender papules on the hands: idiopathic chilblains (perniosis). Arch Dermatol 2006; 142: 1501–6PubMedCrossRef
56.
Zurück zum Zitat Cribier B, Djeridi N, Peltre B, et al. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 2001; 45: 924–9PubMedCrossRef Cribier B, Djeridi N, Peltre B, et al. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 2001; 45: 924–9PubMedCrossRef
57.
Zurück zum Zitat Rustin MH, Newton JA, Smith NP, et al. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol 1989; 120: 267–75PubMedCrossRef Rustin MH, Newton JA, Smith NP, et al. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol 1989; 120: 267–75PubMedCrossRef
58.
Zurück zum Zitat Smith ML. Environmental and sports related skin diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. Spain: Mosby, 2008: 1353–75 Smith ML. Environmental and sports related skin diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. Spain: Mosby, 2008: 1353–75
59.
Zurück zum Zitat Dreno B, Gandon P, Bureau B, et al. Skin lesions from hypersensitivity to cold during chronic myelomonocytic leukaemia. Br J Dermatol 1986; 115: 607–9PubMedCrossRef Dreno B, Gandon P, Bureau B, et al. Skin lesions from hypersensitivity to cold during chronic myelomonocytic leukaemia. Br J Dermatol 1986; 115: 607–9PubMedCrossRef
60.
Zurück zum Zitat Kelly JW, Dowling JP. Pernio: a possible association with chronic myelomonocytic leukemia. Arch Dermatol 1985; 121: 1048–52PubMedCrossRef Kelly JW, Dowling JP. Pernio: a possible association with chronic myelomonocytic leukemia. Arch Dermatol 1985; 121: 1048–52PubMedCrossRef
61.
Zurück zum Zitat Yazawa H, Saga K, Omori F, et al. The chilblain-like eruption as a diagnostic clue to the blast crisis of chronic myelocytic leukemia. J Am Acad Dermatol 2004; 20: S42–4CrossRef Yazawa H, Saga K, Omori F, et al. The chilblain-like eruption as a diagnostic clue to the blast crisis of chronic myelocytic leukemia. J Am Acad Dermatol 2004; 20: S42–4CrossRef
62.
Zurück zum Zitat Fisher DA, Everett MA. Violaceous rash of dorsal fingers in a woman: diagnosis: chilblain lupus erythematosus (perniosis). Arch Dermatol 1996; 132: 459–62PubMedCrossRef Fisher DA, Everett MA. Violaceous rash of dorsal fingers in a woman: diagnosis: chilblain lupus erythematosus (perniosis). Arch Dermatol 1996; 132: 459–62PubMedCrossRef
63.
Zurück zum Zitat Viguier M, Pinquier L, Cavelier-Balloy B, et al. Clinical and histopathologic features and immunologic variable in patients with severe chilblains: a study of the relationship to lupus erythematosus. Medicine (Baltimore) 2001; 80: 180–8CrossRef Viguier M, Pinquier L, Cavelier-Balloy B, et al. Clinical and histopathologic features and immunologic variable in patients with severe chilblains: a study of the relationship to lupus erythematosus. Medicine (Baltimore) 2001; 80: 180–8CrossRef
64.
Zurück zum Zitat Doutre MS, Beylot C, Beylot J, et al. Chilblain lupus erythematosus: report of 15 cases. Dermatology 1992; 184: 26–8PubMedCrossRef Doutre MS, Beylot C, Beylot J, et al. Chilblain lupus erythematosus: report of 15 cases. Dermatology 1992; 184: 26–8PubMedCrossRef
65.
Zurück zum Zitat Boehm I. Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol 2001; 137: 235–6PubMed Boehm I. Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol 2001; 137: 235–6PubMed
67.
Zurück zum Zitat Cohen SJ, Pittelkow MR, Su WP. Cutaneous manifestations of cryoglobulinemia: clinical and histopathological study of seventy-two patients. J Am Acad Dermatol 1991; 25: 21–7PubMedCrossRef Cohen SJ, Pittelkow MR, Su WP. Cutaneous manifestations of cryoglobulinemia: clinical and histopathological study of seventy-two patients. J Am Acad Dermatol 1991; 25: 21–7PubMedCrossRef
68.
Zurück zum Zitat Angello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–5CrossRef Angello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–5CrossRef
69.
Zurück zum Zitat Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775–88PubMedCrossRef Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775–88PubMedCrossRef
70.
Zurück zum Zitat Beightler E, Diven DG, Sanchez RL, et al. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol 1991; 24: 342–5PubMedCrossRef Beightler E, Diven DG, Sanchez RL, et al. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol 1991; 24: 342–5PubMedCrossRef
71.
Zurück zum Zitat Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med 2004; 116: 332–7PubMedCrossRef Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med 2004; 116: 332–7PubMedCrossRef
72.
Zurück zum Zitat Jansen TL, Janssen M, Janssens PM. Transient cryofibrinogenaemia with acral digital necrosis, secondary Raynaud’s phenomenon and polyarthritis. Clin Exp Rheumatol 2003; 21: 407–8PubMed Jansen TL, Janssen M, Janssens PM. Transient cryofibrinogenaemia with acral digital necrosis, secondary Raynaud’s phenomenon and polyarthritis. Clin Exp Rheumatol 2003; 21: 407–8PubMed
73.
Zurück zum Zitat Feizi T. Monotypic cold agglutinins in infection by mycoplasma pneumonia [letter]. Nature 1967; 215: 540PubMedCrossRef Feizi T. Monotypic cold agglutinins in infection by mycoplasma pneumonia [letter]. Nature 1967; 215: 540PubMedCrossRef
74.
Zurück zum Zitat Horwitz CA, Moulds J, Henle W, et al. Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes. Blood 1977; 50: 195–202PubMed Horwitz CA, Moulds J, Henle W, et al. Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes. Blood 1977; 50: 195–202PubMed
75.
Zurück zum Zitat Crisp D, Pruzanski W. B-cell neoplasms with homogenous cold-reacting antibodies (cold agglutinins). Am J Med 1982; 72: 915–22PubMedCrossRef Crisp D, Pruzanski W. B-cell neoplasms with homogenous cold-reacting antibodies (cold agglutinins). Am J Med 1982; 72: 915–22PubMedCrossRef
76.
Zurück zum Zitat Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 1995; 33: 254–8PubMedCrossRef Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 1995; 33: 254–8PubMedCrossRef
77.
Zurück zum Zitat Norgen L, Hiatt WR, Dormandy JA, et al., TASC II Working Group. Intersociety consensus for the management of peripheral arterial disease. J Vasc Surg 2007; 45: S5–67 Norgen L, Hiatt WR, Dormandy JA, et al., TASC II Working Group. Intersociety consensus for the management of peripheral arterial disease. J Vasc Surg 2007; 45: S5–67
78.
Zurück zum Zitat Henke PK. Approach to the patient with acute limb ischemia: diagnosis and therapeutic modalities. Cardiol Clin 2002; 20: 513–20PubMedCrossRef Henke PK. Approach to the patient with acute limb ischemia: diagnosis and therapeutic modalities. Cardiol Clin 2002; 20: 513–20PubMedCrossRef
79.
Zurück zum Zitat Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg 2007; 46: 601–4PubMedCrossRef Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg 2007; 46: 601–4PubMedCrossRef
80.
Zurück zum Zitat Glagett GP, Sobel M, Jackson MR, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 609S–26SCrossRef Glagett GP, Sobel M, Jackson MR, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 609S–26SCrossRef
81.
Zurück zum Zitat Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing, TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463–654CrossRef Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing, TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463–654CrossRef
82.
Zurück zum Zitat Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122: 1194–8PubMedCrossRef Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122: 1194–8PubMedCrossRef
83.
Zurück zum Zitat Ward KM, Celebi JT, Gmyrek R, et al. Acute infectious purpura fulminans associated with asplenism or hyposplenism. J Am Acad Dermatol 2002; 47: 493–6PubMedCrossRef Ward KM, Celebi JT, Gmyrek R, et al. Acute infectious purpura fulminans associated with asplenism or hyposplenism. J Am Acad Dermatol 2002; 47: 493–6PubMedCrossRef
84.
Zurück zum Zitat Childers BJ, Cobanov B. Acute infectious purpura fulminans: a 15-year retrospective review of 28 consecutive cases. Am Surg 2003; 69: 86–90PubMed Childers BJ, Cobanov B. Acute infectious purpura fulminans: a 15-year retrospective review of 28 consecutive cases. Am Surg 2003; 69: 86–90PubMed
85.
Zurück zum Zitat Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol 1985; 121: 1057–61PubMedCrossRef Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol 1985; 121: 1057–61PubMedCrossRef
86.
Zurück zum Zitat Davis MD, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J Am Acad Dermatol 2007; 57: 944–56PubMedCrossRef Davis MD, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J Am Acad Dermatol 2007; 57: 944–56PubMedCrossRef
87.
Zurück zum Zitat Tack CJ, Lenders JW. Pheochromocytoma as a cause of blue toes [letter]. Arch Intern Med 1993; 153: 2061PubMedCrossRef Tack CJ, Lenders JW. Pheochromocytoma as a cause of blue toes [letter]. Arch Intern Med 1993; 153: 2061PubMedCrossRef
88.
Zurück zum Zitat Bhalla A, Gupta S, Jain AP, et al. Blue toe syndrome: a rare complication of acute pancreatitis. JOP 2003; 4: 17–9PubMed Bhalla A, Gupta S, Jain AP, et al. Blue toe syndrome: a rare complication of acute pancreatitis. JOP 2003; 4: 17–9PubMed
89.
Zurück zum Zitat Berman DA, Roenigk HH, Green D. Autoerythrocyte sensitization syndrome (psychogenic purpura). J Am Acad Dermatol 1992; 27: 829–32PubMedCrossRef Berman DA, Roenigk HH, Green D. Autoerythrocyte sensitization syndrome (psychogenic purpura). J Am Acad Dermatol 1992; 27: 829–32PubMedCrossRef
90.
Zurück zum Zitat Layton AM, Cotterill JA. A case of Achenbach’s syndrome. Clin Exp Dermatol 1993; 18: 60–1PubMedCrossRef Layton AM, Cotterill JA. A case of Achenbach’s syndrome. Clin Exp Dermatol 1993; 18: 60–1PubMedCrossRef
91.
Zurück zum Zitat Robertson A, Liddington MI, Kay SP. Paroxysmal finger haematomas (Achenbach’s syndrome) with angiographic abnormalities. J Hand Surg Br 2002; 27: 391–3PubMed Robertson A, Liddington MI, Kay SP. Paroxysmal finger haematomas (Achenbach’s syndrome) with angiographic abnormalities. J Hand Surg Br 2002; 27: 391–3PubMed
92.
Zurück zum Zitat Marconi V, Mofid MZ, McCall C, et al. Primary hyperoxaluria: report of a patient with livedo reticularis and digital infarcts. J Am Acad Dermatol 2002; 46 (2 Suppl. Case Reports): S16–8CrossRef Marconi V, Mofid MZ, McCall C, et al. Primary hyperoxaluria: report of a patient with livedo reticularis and digital infarcts. J Am Acad Dermatol 2002; 46 (2 Suppl. Case Reports): S16–8CrossRef
93.
Zurück zum Zitat Spiers EM, Sanders DY, Omura EF. Clinical and histologic features of primary oxalosis. J Am Acad Dermatol 1990; 22: 952–6PubMedCrossRef Spiers EM, Sanders DY, Omura EF. Clinical and histologic features of primary oxalosis. J Am Acad Dermatol 1990; 22: 952–6PubMedCrossRef
94.
95.
Zurück zum Zitat Scheinman PL, Helm KF, Fairley JA. Acral necrosis in a patient with chronic renal failure: calciphylaxis. Arch Dermatol 1991; 127: 248–9PubMedCrossRef Scheinman PL, Helm KF, Fairley JA. Acral necrosis in a patient with chronic renal failure: calciphylaxis. Arch Dermatol 1991; 127: 248–9PubMedCrossRef
96.
Zurück zum Zitat Hafner J, Keusch G, Wahl C, et al. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998; 27: 137–43PubMed Hafner J, Keusch G, Wahl C, et al. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998; 27: 137–43PubMed
97.
Zurück zum Zitat Ackermann F, Levy A, Daugas E, et al. Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol 2007; 143: 1336–7PubMedCrossRef Ackermann F, Levy A, Daugas E, et al. Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol 2007; 143: 1336–7PubMedCrossRef
98.
Zurück zum Zitat Baker BL, Fitzgibbons CA, Buescher LS. Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol 2007; 143: 269–70PubMedCrossRef Baker BL, Fitzgibbons CA, Buescher LS. Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol 2007; 143: 269–70PubMedCrossRef
99.
Zurück zum Zitat Robinson MR, Augustine JJ, Korman NJ. Cinacalcet for the treatment of calciphylaxis. Arch Dermatol 2007; 143: 152–4PubMedCrossRef Robinson MR, Augustine JJ, Korman NJ. Cinacalcet for the treatment of calciphylaxis. Arch Dermatol 2007; 143: 152–4PubMedCrossRef
100.
Zurück zum Zitat Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 38: 769–84PubMedCrossRef Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 38: 769–84PubMedCrossRef
101.
Zurück zum Zitat Pelle MT, Miller F. Dermatologic manifestations and management of vascular steal syndrome in hemodialysis patients with arteriovenous fistulas. Arch Dermatol 2002; 138: 1296–8PubMedCrossRef Pelle MT, Miller F. Dermatologic manifestations and management of vascular steal syndrome in hemodialysis patients with arteriovenous fistulas. Arch Dermatol 2002; 138: 1296–8PubMedCrossRef
102.
Zurück zum Zitat Karmody AM, Powers SR, Monaco VJ, et al. ‘Blue toe’ syndrome: an indication for limb salvage surgery. Arch Surg 1976; 111: 1263–8PubMedCrossRef Karmody AM, Powers SR, Monaco VJ, et al. ‘Blue toe’ syndrome: an indication for limb salvage surgery. Arch Surg 1976; 111: 1263–8PubMedCrossRef
103.
Zurück zum Zitat Keen RR, McCarthy WJ, Shireman PK, et al. Surgical management of atheroembolization. J Vas Surg 1995; 21: 773–80CrossRef Keen RR, McCarthy WJ, Shireman PK, et al. Surgical management of atheroembolization. J Vas Surg 1995; 21: 773–80CrossRef
104.
Zurück zum Zitat Baumann DS, McGraw D, Rubin BG, et al. An institutional experience with arterial atheroembolism. Ann Vasc Surg 1994; 8: 258–65PubMedCrossRef Baumann DS, McGraw D, Rubin BG, et al. An institutional experience with arterial atheroembolism. Ann Vasc Surg 1994; 8: 258–65PubMedCrossRef
105.
Zurück zum Zitat Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation 2006; 114: 63–75PubMedCrossRef Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation 2006; 114: 63–75PubMedCrossRef
106.
Zurück zum Zitat Fukumoto Y, Tsutsui H, Tsuchihasi M, et al., Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42: 211–6 Fukumoto Y, Tsutsui H, Tsuchihasi M, et al., Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42: 211–6
107.
Zurück zum Zitat Feder W, Auerbach R. ‘Purple toes’: an uncommon sequel of oral coumarin drug therapy. Ann Intern Med 1961; 55: 911–7PubMed Feder W, Auerbach R. ‘Purple toes’: an uncommon sequel of oral coumarin drug therapy. Ann Intern Med 1961; 55: 911–7PubMed
108.
Zurück zum Zitat Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002; 90: 1320–5PubMedCrossRef Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002; 90: 1320–5PubMedCrossRef
109.
Zurück zum Zitat Tunick PA, Perez JL, Krozon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991; 115: 423–7PubMed Tunick PA, Perez JL, Krozon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991; 115: 423–7PubMed
110.
Zurück zum Zitat Blachshear JL, Oldenburg WA, Cohen MD. Making the diagnosis when the patient has ‘blue toes’. Geriatrics 1994; 49: 37–45 Blachshear JL, Oldenburg WA, Cohen MD. Making the diagnosis when the patient has ‘blue toes’. Geriatrics 1994; 49: 37–45
111.
Zurück zum Zitat Cheu HW, Mills JL. Digital artery embolization as a result of fibromuscular dysplasia of the brachial artery. J Vasc Surg 1991; 14: 225–8PubMedCrossRef Cheu HW, Mills JL. Digital artery embolization as a result of fibromuscular dysplasia of the brachial artery. J Vasc Surg 1991; 14: 225–8PubMedCrossRef
112.
Zurück zum Zitat Longo GM, Friedman AC, Hollins RR, et al. Distal radial artery lesion as a source of digital emboli. J Vasc Surg 1998; 28: 710–4PubMedCrossRef Longo GM, Friedman AC, Hollins RR, et al. Distal radial artery lesion as a source of digital emboli. J Vasc Surg 1998; 28: 710–4PubMedCrossRef
113.
Zurück zum Zitat Renshaw A, McCown T, Waltke EA, et al. Angioplasty with stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg 2002; 36: 155–9PubMedCrossRef Renshaw A, McCown T, Waltke EA, et al. Angioplasty with stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg 2002; 36: 155–9PubMedCrossRef
114.
Zurück zum Zitat Stone MS, Rosen T. Acral purpura: an unusual sign of coumarin necrosis. J Am Acad Dermatol 1986; 14: 797–802PubMedCrossRef Stone MS, Rosen T. Acral purpura: an unusual sign of coumarin necrosis. J Am Acad Dermatol 1986; 14: 797–802PubMedCrossRef
115.
Zurück zum Zitat Park S, Schroeter AL, Park YS, et al. Purple toes and livido reticularis in a patient with cardiovascular disease taking coumadin. Arch Derm 1993; 129 (6): 777–80PubMedCrossRef Park S, Schroeter AL, Park YS, et al. Purple toes and livido reticularis in a patient with cardiovascular disease taking coumadin. Arch Derm 1993; 129 (6): 777–80PubMedCrossRef
116.
Zurück zum Zitat Queen M, Biem HJ, Moe GW, et al. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction. Am J Cardiol 1990; 65: 1042–3PubMedCrossRef Queen M, Biem HJ, Moe GW, et al. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction. Am J Cardiol 1990; 65: 1042–3PubMedCrossRef
117.
Zurück zum Zitat Ridker PM, Michel T. Streptokinase therapy and cholesterol embolization. Am J Med 1989; 87: 357–8PubMedCrossRef Ridker PM, Michel T. Streptokinase therapy and cholesterol embolization. Am J Med 1989; 87: 357–8PubMedCrossRef
118.
Zurück zum Zitat Schwartz MW, McDonald GB. Cholesterol embolization syndrome: occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 1987; 258: 1934–5PubMedCrossRef Schwartz MW, McDonald GB. Cholesterol embolization syndrome: occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 1987; 258: 1934–5PubMedCrossRef
119.
Zurück zum Zitat Conn DL, Tompkins RB, Nichols WL. Glucocorticoids in the management of vasculitis: a double edged sword? J Rheumatol 1988; 15: 1181–3PubMed Conn DL, Tompkins RB, Nichols WL. Glucocorticoids in the management of vasculitis: a double edged sword? J Rheumatol 1988; 15: 1181–3PubMed
120.
Zurück zum Zitat Davies GE, Triplett DA. Corticosteroid-associated blue toe syndrome: role of antiphospholipid antibodies. Ann Intern Med 1990; 113: 893–5PubMed Davies GE, Triplett DA. Corticosteroid-associated blue toe syndrome: role of antiphospholipid antibodies. Ann Intern Med 1990; 113: 893–5PubMed
121.
Zurück zum Zitat Chang JC. Review: postoperative thrombocytopenia: with etiologic, diagnostic, and therapeutic consideration. Am J Med Sci 1996; 311: 96–105PubMedCrossRef Chang JC. Review: postoperative thrombocytopenia: with etiologic, diagnostic, and therapeutic consideration. Am J Med Sci 1996; 311: 96–105PubMedCrossRef
122.
Zurück zum Zitat Perman M, Sterling JB, Gaspari A. The painful purple digit: an alarming complication of Candida albicans antigen treatment or recalcitrant warts. Dermatitis 2005; 16: 38–40PubMedCrossRef Perman M, Sterling JB, Gaspari A. The painful purple digit: an alarming complication of Candida albicans antigen treatment or recalcitrant warts. Dermatitis 2005; 16: 38–40PubMedCrossRef
123.
Zurück zum Zitat Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57: 413–20PubMedCrossRef Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57: 413–20PubMedCrossRef
124.
Zurück zum Zitat Rallis E, Koumantaki-Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections. Exper Opin Pharmacother 2007; 8: 2965–78CrossRef Rallis E, Koumantaki-Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections. Exper Opin Pharmacother 2007; 8: 2965–78CrossRef
125.
Zurück zum Zitat Bhatty MA, Turner DP, Chamberlain ST. Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg 2000; 53: 161–5PubMedCrossRef Bhatty MA, Turner DP, Chamberlain ST. Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg 2000; 53: 161–5PubMedCrossRef
126.
Zurück zum Zitat Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection. Arch Intern Med 2002; 162: 1746–52PubMedCrossRef Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection. Arch Intern Med 2002; 162: 1746–52PubMedCrossRef
127.
Zurück zum Zitat Hartmark-Hill JR, Kanodia AK, Frey KA. 53-year-old man with a swollen finger. Mayo Clin Proc 2008; 83: 217–20PubMed Hartmark-Hill JR, Kanodia AK, Frey KA. 53-year-old man with a swollen finger. Mayo Clin Proc 2008; 83: 217–20PubMed
128.
Zurück zum Zitat Rosato FE, Rosato EF, Plotkin SA. Herpetic paronychia: an occupational hazard of medical personnel. N Engl J Med 1970; 283: 804–5PubMedCrossRef Rosato FE, Rosato EF, Plotkin SA. Herpetic paronychia: an occupational hazard of medical personnel. N Engl J Med 1970; 283: 804–5PubMedCrossRef
129.
Zurück zum Zitat Kuo YL, Shieh SJ, Chiu HY, et al. Necrotizing fasciitis by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis 2007; 26: 785–92PubMedCrossRef Kuo YL, Shieh SJ, Chiu HY, et al. Necrotizing fasciitis by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis 2007; 26: 785–92PubMedCrossRef
130.
Zurück zum Zitat Chang-Chien CH, Ding HT, Liu C, et al. Vibrio infection associated with finning injury of the hand. Injury 2007; 38: 614–8PubMedCrossRef Chang-Chien CH, Ding HT, Liu C, et al. Vibrio infection associated with finning injury of the hand. Injury 2007; 38: 614–8PubMedCrossRef
131.
132.
Zurück zum Zitat Brooke CJ, Riley TV. Eryipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999; 48: 789–99PubMedCrossRef Brooke CJ, Riley TV. Eryipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999; 48: 789–99PubMedCrossRef
133.
Zurück zum Zitat Baker AS, Ruoff KL, Madoff S. Isolation of mycoplasma species from a patient with seal finger. Clin Infect Dis 1998; 27: 1168–70PubMedCrossRef Baker AS, Ruoff KL, Madoff S. Isolation of mycoplasma species from a patient with seal finger. Clin Infect Dis 1998; 27: 1168–70PubMedCrossRef
134.
136.
Zurück zum Zitat Aleksic M, Heckenkamp J, Gawenda M, et al. Occupation-related vascular disorders of the upper extremity: two case reports. Angiology 2006; 57: 107–14PubMedCrossRef Aleksic M, Heckenkamp J, Gawenda M, et al. Occupation-related vascular disorders of the upper extremity: two case reports. Angiology 2006; 57: 107–14PubMedCrossRef
137.
Zurück zum Zitat Marques E. Ulnar artery thrombosis: hypothenar hammer syndrome. J Am Coll Surg 2008; 206: 188–9PubMedCrossRef Marques E. Ulnar artery thrombosis: hypothenar hammer syndrome. J Am Coll Surg 2008; 206: 188–9PubMedCrossRef
138.
Zurück zum Zitat Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger’s disease). Vasc Surg 1992; 5: 1–18 Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger’s disease). Vasc Surg 1992; 5: 1–18
139.
Zurück zum Zitat Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med 2000; 343: 846–9CrossRef Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med 2000; 343: 846–9CrossRef
140.
Zurück zum Zitat Federman DG, Valdivia M, Kirsner RS. Syphilis presenting as the ‘blue toe syndrome.’ Arch Intern Med 1994; 154: 1029–31PubMedCrossRef Federman DG, Valdivia M, Kirsner RS. Syphilis presenting as the ‘blue toe syndrome.’ Arch Intern Med 1994; 154: 1029–31PubMedCrossRef
141.
Zurück zum Zitat Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol 2006; 24: 414–29PubMedCrossRef Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol 2006; 24: 414–29PubMedCrossRef
142.
Zurück zum Zitat Francés C, Du LT, Piette JC, et al. Wegener’s granulomatosis: dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994; 130: 861–7PubMedCrossRef Francés C, Du LT, Piette JC, et al. Wegener’s granulomatosis: dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994; 130: 861–7PubMedCrossRef
143.
Zurück zum Zitat Avcin T, Singh-Grewal D, Silverman ED, et al. Severe digital ischaemia in a child with Wegener’s granulomatosis. Scand J Rheumatol 2007; 36: 78–80PubMedCrossRef Avcin T, Singh-Grewal D, Silverman ED, et al. Severe digital ischaemia in a child with Wegener’s granulomatosis. Scand J Rheumatol 2007; 36: 78–80PubMedCrossRef
144.
Zurück zum Zitat Stussi G, Schneider E, Trüeb RM, et al. Acral necrosis of the fingers as initial manifestation of cutaneous polyarteritis nodosa: a case report. Angiology 2001; 52: 63–7PubMedCrossRef Stussi G, Schneider E, Trüeb RM, et al. Acral necrosis of the fingers as initial manifestation of cutaneous polyarteritis nodosa: a case report. Angiology 2001; 52: 63–7PubMedCrossRef
145.
Zurück zum Zitat Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol 2001; 13: 23–34PubMedCrossRef Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol 2001; 13: 23–34PubMedCrossRef
146.
Zurück zum Zitat Mallia C, Coleiro B, Crockford M, et al. Raynaud’s phenomenon caused by giant cell arteritis: a case report. Adv Exp Med Biol 1999; 455: 517–20PubMedCrossRef Mallia C, Coleiro B, Crockford M, et al. Raynaud’s phenomenon caused by giant cell arteritis: a case report. Adv Exp Med Biol 1999; 455: 517–20PubMedCrossRef
147.
Zurück zum Zitat Elgart ML. Cutaneous sarcoidosis: definitions and type of lesions. Clin Dermatol 1986; 4 (4): 35–45PubMedCrossRef Elgart ML. Cutaneous sarcoidosis: definitions and type of lesions. Clin Dermatol 1986; 4 (4): 35–45PubMedCrossRef
148.
Zurück zum Zitat Young RJ, Gilson RT, Yanse D, et al. Cutaneous sarcoidosis. Int J Dermatol 2001; 40: 249–53PubMedCrossRef Young RJ, Gilson RT, Yanse D, et al. Cutaneous sarcoidosis. Int J Dermatol 2001; 40: 249–53PubMedCrossRef
149.
Zurück zum Zitat Cohen JS. Erythromelalgia: New theories and new therapies. J Am Acad Dermatol 2000; 43: 841–7PubMedCrossRef Cohen JS. Erythromelalgia: New theories and new therapies. J Am Acad Dermatol 2000; 43: 841–7PubMedCrossRef
150.
Zurück zum Zitat Michiels JJ, Abels J, Steketee J, et al. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 1985; 102: 466–71PubMed Michiels JJ, Abels J, Steketee J, et al. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 1985; 102: 466–71PubMed
151.
Zurück zum Zitat Michiels JJ, Bernman Z, Schroyens W, et al. Aspiring-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Ann Hematol 2003; 82: 153–9PubMed Michiels JJ, Bernman Z, Schroyens W, et al. Aspiring-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Ann Hematol 2003; 82: 153–9PubMed
152.
Zurück zum Zitat Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004; 350: 114–24PubMedCrossRef Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004; 350: 114–24PubMedCrossRef
153.
Zurück zum Zitat Kesler A, Ellis MH, Manor Y, et al. Neurolgical complications of essential thrombocytosis (ET). Acta Neurol Scand 2000; 102: 299–302PubMedCrossRef Kesler A, Ellis MH, Manor Y, et al. Neurolgical complications of essential thrombocytosis (ET). Acta Neurol Scand 2000; 102: 299–302PubMedCrossRef
154.
Zurück zum Zitat Papadonikolakis A, Chloros GD, Smith BP, et al. Digital ischemia due to essential thrombocythemia: a case report. J Hand Surg 2007; 32A: 1053–7 Papadonikolakis A, Chloros GD, Smith BP, et al. Digital ischemia due to essential thrombocythemia: a case report. J Hand Surg 2007; 32A: 1053–7
155.
Zurück zum Zitat Hussain S, Schwartz JM, Friedman SA, et al. Arterial thrombosis in essential thrombocythemia. Am Heart J 1978; 96: 31–6PubMedCrossRef Hussain S, Schwartz JM, Friedman SA, et al. Arterial thrombosis in essential thrombocythemia. Am Heart J 1978; 96: 31–6PubMedCrossRef
Metadaten
Titel
The Purple Digit
An Algorithmic Approach to Diagnosis
verfasst von
Patrick J. Brown
Matthew J. Zirwas
Dr Joseph C. English III
Publikationsdatum
01.04.2010
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 2/2010
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/11530180-000000000-00000

Weitere Artikel der Ausgabe 2/2010

American Journal of Clinical Dermatology 2/2010 Zur Ausgabe

Review Article

Gardner Syndrome

Review Article

Photoaging

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.